Nisshin Seifun Group Inc.
Nisshin Seifun Group Inc. (NSFMF) Financial Performance & Income Statement Overview
Analyze Nisshin Seifun Group Inc. (NSFMF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Nisshin Seifun Group Inc. (NSFMF) Income Statement & Financial Overview
Explore comprehensive income reports for Nisshin Seifun Group Inc. NSFMF, broken down by year and quarter.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $204.04B | $217.93B | $215.64B | $213.87B |
Cost of Revenue | $160.74B | $168.20B | $167.05B | $165.31B |
Gross Profit | $43.30B | $49.72B | $48.59B | $48.56B |
Gross Profit Ratio | $0.21 | $0.23 | $0.23 | $0.23 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $36.39B | $36.26B | $35.80B | $35.34B |
Operating Expenses | $36.39B | $36.26B | $35.80B | $35.34B |
Total Costs & Expenses | $197.13B | $204.47B | $202.85B | $200.65B |
Interest Income | $287.00M | $0.00 | $218.00M | $229.00M |
Interest Expense | $928.00M | $0.00 | $948.00M | $987.00M |
Depreciation & Amortization | $6.50B | $6.07B | $6.10B | $6.07B |
EBITDA | $14.26B | $19.53B | $21.64B | $19.29B |
EBITDA Ratio | $0.07 | $0.09 | $0.10 | $0.09 |
Operating Income | $6.91B | $13.46B | $12.79B | $13.22B |
Operating Income Ratio | $0.03 | $0.06 | $0.06 | $0.06 |
Other Income/Expenses (Net) | $215.00M | $1.72B | $1.80B | $3.20B |
Income Before Tax | $7.13B | $15.18B | $14.59B | $16.42B |
Income Before Tax Ratio | $0.03 | $0.07 | $0.07 | $0.08 |
Income Tax Expense | $2.74B | $4.67B | $4.75B | $5.22B |
Net Income | $4.15B | $10.18B | $9.52B | $10.85B |
Net Income Ratio | $0.02 | $0.05 | $0.04 | $0.05 |
EPS | $14.28 | $34.21 | $32.02 | $36.46 |
Diluted EPS | $14.28 | $34.21 | $32.02 | $36.46 |
Weighted Avg Shares Outstanding | $290.31M | $297.42M | $297.28M | $297.43M |
Weighted Avg Shares Outstanding (Diluted) | $290.31M | $297.42M | $297.28M | $297.43M |
Over the past four quarters, Nisshin Seifun Group Inc. demonstrated steady revenue growth, increasing from $213.87B in Q1 2024 to $204.04B in Q4 2024. Operating income reached $6.91B in Q4 2024, maintaining a consistent 3% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $14.26B, reflecting operational efficiency. Net income dropped to $4.15B, with EPS at $14.28. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan